Linked Life Data

15612660

Source:http://linkedlifedata.com/resource/pubmed/id/15612660

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-12-22
pubmed:abstractText
The incidence of pancreatic cancer is increasing in China, and in many patients the surrounding lymphatics have already been invaded and there is blood-borne metastasis at the time of diagnosis. Additionally, pancreatic cancer is largely refractory to conventional therapies. Therefore, to improve its prognosis, it is important to resolve the problem of its growth. Angiotensin II type 1 receptor (AT1) stimulates the growth and angiogenesis of pancreatic cancer and a selective AT1 antagonist could inhibit these effects. The present study aimed to investigate the expression of AT1 in pancreatic cancer cell lines to provide the theoretical basis for its treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1443-9611
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-71
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines.
pubmed:affiliation
Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. jiangh66@yahoo.com
pubmed:publicationType
Journal Article